Retraction Note: Emerging insights into the role of IL-1 inhibitors and colchicine for inflammation control in type 2 diabetes
Diabetol Metab Syndr
.
2025 Jan 20;17(1):21.
doi: 10.1186/s13098-025-01596-w.
Authors
Jianbin Guan
1
,
Haimiti Abudouaini
1
,
Kaiyuan Lin
2
,
Kaitan Yang
3
4
Affiliations
1
Honghui-Hospital, Xi'an Jiaotong University, Xi'an, 710054, Shaanxi, China.
2
Honghui-Hospital, Xi'an Jiaotong University, Xi'an, 710054, Shaanxi, China. kaiyuanlin1208@163.com.
3
Honghui-Hospital, Xi'an Jiaotong University, Xi'an, 710054, Shaanxi, China. 15652386716@163.com.
4
Truma Rehabilitation Department, Honghui-Hospital, Xi'an Jiaotong University, Xi'an, 710054, Shaanxi, China. 15652386716@163.com.
PMID:
39828696
PMCID:
PMC11744967
DOI:
10.1186/s13098-025-01596-w
No abstract available
Publication types
Retraction of Publication